• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体碘需求与碘盐的安全使用。

Human requirements of iodine & safe use of iodised salt.

作者信息

Ranganathan S, Reddy V

机构信息

National Institute of Nutrition, Hyderabad.

出版信息

Indian J Med Res. 1995 Nov;102:227-32.

PMID:8675243
Abstract

Iodine deficiency is the most common preventable cause of mental deficiency. Remarkable success has been achieved by the use of iodised salt to correct this deficiency in many industrialised countries since 1920. The Government of India has adopted a strategy to iodise all edible salt in the country to overcome iodine deficiency. Universal salt iodisation is the principal public health measure for eliminating iodine deficiency disorders. Daily iodine intakes of up to 1000 micrograms, appear to be entirely safe. In India, the likelihood of exceeding this level is quite small. Iodised salt does not cause any side effects. Iodine in iodised salt does not carry risks for persons who are already iodine sufficient. iodisation of salt at the current level of fortification (15-30 ppm iodine) keeps intakes well within a safe daily range for all populations, irrespective of their iodine status.

摘要

碘缺乏是导致智力缺陷最常见的可预防原因。自1920年以来,许多工业化国家通过使用加碘盐来纠正这种缺乏,已取得显著成效。印度政府已采取一项战略,对该国所有食用盐进行碘化处理,以克服碘缺乏问题。全民食盐碘化是消除碘缺乏病的主要公共卫生措施。每日碘摄入量高达1000微克似乎完全安全。在印度,超过这一水平的可能性很小。加碘盐不会引起任何副作用。加碘盐中的碘对碘摄入已充足的人没有风险。按照目前的强化水平(碘含量为15 - 30 ppm)对盐进行碘化处理,可使所有人群的摄入量保持在安全的每日范围内,无论其碘状况如何。

相似文献

1
Human requirements of iodine & safe use of iodised salt.人体碘需求与碘盐的安全使用。
Indian J Med Res. 1995 Nov;102:227-32.
2
Iodised salt is safe.加碘盐是安全的。
Indian J Public Health. 1995 Oct-Dec;39(4):164-71.
3
Indicators to monitor progress of National Iodine Deficiency Disorders Control Programme (NIDDCP) and some observations on iodised salt in west Bengal.监测国家碘缺乏病控制项目(NIDDCP)进展的指标以及对西孟加拉邦碘盐的一些观察
Indian J Public Health. 1995 Oct-Dec;39(4):141-7.
4
Epidemiology of iodine deficiency: Salt iodisation and iodine status.碘缺乏症的流行病学:盐碘化和碘状况。
Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):1-11. doi: 10.1016/j.beem.2009.08.005.
5
The evaluation of the iodine content of table salt in Lesotho.莱索托食盐碘含量评估
Afr J Health Sci. 2002 Jul-Dec;9(3-4):139-45.
6
Persistence of iodine deficiency in Gangetic flood-prone area, West Bengal, India.印度西孟加拉邦恒河洪水多发地区碘缺乏问题的持续存在。
Asia Pac J Clin Nutr. 2006;15(4):528-32.
7
Dr. P. C. Sen Memorial Award Paper. Status of salt iodisation and iodine deficiency in selected districts of different states of India.P. C. 森博士纪念奖论文。印度不同邦部分地区的食盐碘化状况与碘缺乏情况
Indian J Public Health. 1998 Jul-Sep;42(3):75-80.
8
National Iodine Deficiency Disorders Control Programme in India.印度全国碘缺乏病控制计划
Indian J Public Health. 1995 Oct-Dec;39(4):148-51.
9
Status of iodine nutriture and universal salt iodisation at beneficiaries levels in Kerala State, India.印度喀拉拉邦受益人群的碘营养状况及全民食盐加碘情况
J Indian Med Assoc. 2006 Apr;104(4):165-7.
10
Iodine-deficiency disorders.碘缺乏症
Lancet. 2008 Oct 4;372(9645):1251-62. doi: 10.1016/S0140-6736(08)61005-3.

引用本文的文献

1
Reappraisal of the risk of iodine-induced hyperthyroidism: an epidemiological population survey.碘致甲状腺功能亢进症风险的重新评估:一项流行病学人群调查。
J Endocrinol Invest. 2005 Jan;28(1):23-9. doi: 10.1007/BF03345525.